
Nasser H. Hanna, MD, discusses his approach to biomarker testing in lung cancer.

Nasser H. Hanna, MD, discusses his approach to biomarker testing in lung cancer.

Nasser Hanna, MD, Tom and Julie Wood Family Foundation Professor of Lung Cancer Clinical Research, at Indiana University Melvin and Bren Simon Cancer Center, discusses the efficacy of consolidation immunotherapy in patients with stage III non–small cell lung cancer.

March 18th 2021

November 12th 2018